UA89180C2 - Drospirenone for hormone replacement therapy - Google Patents
Drospirenone for hormone replacement therapyInfo
- Publication number
- UA89180C2 UA89180C2 UAA200612100A UAA200612100A UA89180C2 UA 89180 C2 UA89180 C2 UA 89180C2 UA A200612100 A UAA200612100 A UA A200612100A UA A200612100 A UAA200612100 A UA A200612100A UA 89180 C2 UA89180 C2 UA 89180C2
- Authority
- UA
- Ukraine
- Prior art keywords
- drospirenone
- estrogene
- replacement therapy
- hormone replacement
- active component
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to pharmaceutical composition for hormone replacement therapy containing as a first active component a sufficient amount of estrogene such as estradiol or estradiol valerate to cure diseases, abnormalities and symptoms caused by the insufficient autogenous level of estrogene in woman, and as a second active component a sufficient amount of 6,7,15,16-dimethylene-3-oxo-17-preg-4-ene-21,17-carbolactone (drospirenone, DRSP) to protect an endometrium from a side effect of estrogene is useful especially for women near, in and after menopause.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00200183 | 2000-01-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
UA89180C2 true UA89180C2 (en) | 2010-01-11 |
Family
ID=38170612
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UA2002086809A UA81388C2 (en) | 2000-01-18 | 2001-01-18 | Pharmaceutical composition comprising estrogen and drospirenone for hormone replacement therapy |
UAA200612100A UA89180C2 (en) | 2000-01-18 | 2001-01-18 | Drospirenone for hormone replacement therapy |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UA2002086809A UA81388C2 (en) | 2000-01-18 | 2001-01-18 | Pharmaceutical composition comprising estrogen and drospirenone for hormone replacement therapy |
Country Status (7)
Country | Link |
---|---|
AR (1) | AR035633A1 (en) |
CO (1) | CO5280075A1 (en) |
HR (1) | HRP20070360B1 (en) |
JO (1) | JO2334B1 (en) |
PE (1) | PE20011051A1 (en) |
SA (1) | SA01210754B1 (en) |
UA (2) | UA81388C2 (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4426601A1 (en) * | 1994-07-27 | 1996-02-01 | Schering Ag | Use of a combination product containing a competitive progesterone antagonist and a progestogen for the manufacture of a medicament for the treatment of endometriosis or Leiomyomata uteri |
DE19654609A1 (en) * | 1996-12-20 | 1998-06-25 | Schering Ag | Therapeutic progestogens for the treatment of premenstrual dysphoric disorder |
JP4354667B2 (en) * | 1999-08-31 | 2009-10-28 | バイエル・シエーリング・ファーマ・アクチエンゲゼルシャフト | Medicinal combination of ethinylestradiol and drospirenone for use as a contraceptive |
-
2001
- 2001-01-11 JO JO200110A patent/JO2334B1/en active
- 2001-01-15 PE PE2001000035A patent/PE20011051A1/en active IP Right Grant
- 2001-01-17 AR ARP010100199 patent/AR035633A1/en not_active Application Discontinuation
- 2001-01-17 CO CO01003045A patent/CO5280075A1/en not_active Application Discontinuation
- 2001-01-18 UA UA2002086809A patent/UA81388C2/en unknown
- 2001-01-18 UA UAA200612100A patent/UA89180C2/en unknown
- 2001-03-21 SA SA01210754A patent/SA01210754B1/en unknown
-
2007
- 2007-08-17 HR HRP20070360AA patent/HRP20070360B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JO2334B1 (en) | 2006-06-28 |
SA01210754B1 (en) | 2007-02-17 |
HRP20070360B1 (en) | 2014-11-21 |
AR035633A1 (en) | 2004-06-23 |
UA81388C2 (en) | 2008-01-10 |
HRP20070360A2 (en) | 2008-12-31 |
CO5280075A1 (en) | 2003-05-30 |
PE20011051A1 (en) | 2001-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
YU54602A (en) | Drospirenone for hormone replacement therapy | |
EA200201000A1 (en) | HORMONE-DESTINY THERAPY | |
RO115115B1 (en) | Hormone replacement therapy | |
HK1054332A1 (en) | Novel topical oestroprogestational compositions with systemic effect | |
NZ516502A (en) | Administration of non-oral androgenic steroids to women having an elevated level of sex hormone binding globulin (SHBG) | |
IL122432A0 (en) | Transdermal patch for preventing ovulation | |
WO2006053172A3 (en) | The use of estriol and other estranes, estrogens and estrogen receptor active compositions in the treatment of psoriasis and other autoimmune diseases | |
HRP20030387A2 (en) | Use of antiprogestins for prophylaxis and treatment of hormone dependent diseases | |
CA2581927C (en) | Treatment or prevention of unscheduled bleeding in women on progestogen containing medication | |
US20120225853A1 (en) | Hormone replacement therapy and depression | |
UA89180C2 (en) | Drospirenone for hormone replacement therapy | |
AU759925B2 (en) | Oral contraceptive preparation having a first phase comprising progestin/estrogen and a second phase comprising progestin | |
CA2261748A1 (en) | Biphasic contraceptive method and kit comprising a combination of a progestin and estrogen | |
CA2248841A1 (en) | Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy | |
WO2003084521A3 (en) | Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy | |
HRP20020666A8 (en) | Drospirenone for hormone replacement therapy | |
EA007840B1 (en) | Mesoprogestins (progesterone receptor modulator) as a component of compositions for hormone replacement therapy (hrt) | |
WO2000067708A3 (en) | Oral steroidal hormone compositions and methods of use | |
CA2421302A1 (en) | 4-halogenated 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds | |
Oelkers | The renin–aldosterone system and drospirenone | |
UY26539A1 (en) | DROSPIRENONE FOR HORMONE REPLACEMENT THERAPY. | |
CA2388237A1 (en) | Treatment of osteoporosis | |
YU30103A (en) | Use of antiprogestins for prophylaxis and treatment of hormone dependent diseases | |
AU5942700A (en) | Sequential estrogen/progestrone antagonist combination for hormone replacement theapy | |
de Gaetano et al. | Cardiovascular Disease: Risk Factors Related to Thrombosis |